|
Risk management is a priority issue because it affects every part of the business. It is pre-emptive process that allows the
Group and Company to assess and analyse risk in an integrated fashion, identifying potential areas in advance and then
to proactively create processes and measures for compliance.
Fundamentally, the Board’s responsibility in managing risk is to protect the Group’s employees, stakeholders and the Group
in every facet. It fully accepts overall responsibility for risk management and internal control and in so doing the Board has
deployed effective control mechanisms to prevent and mitigate the impact of risk.
Primary responsibility for risk management at an operational level rests with the Executive Committee. Management and
various specialist Committees are tasked with integrating the management of risk into the day-to-day activities of the
Group and Company. Refer to the corporate governance statement in the Annual Integrated Report for more detail
regarding the Executive Committee’s involved in risk management.
The healthcare and administration business activities are exposed to a variety of financial risks:
- market risk;
- credit risk; and
- liquidity risk.
The Group’s and Company’s overall risk management programme focuses on the unpredictability of financial markets and
seeks to minimise potential adverse effects on the Group’s financial performance.
Refer to note 8 for classes of financial assets and liabilities.
Price risk
The Group and Company investments in collective investment schemes are subject to the terms and conditions of the
respective collective investment schemes offering documentation and are susceptible to market price risk arising from
uncertainties about future values of those collective investment schemes. The investment manager makes investment
decisions after extensive due diligence of the underlying fund, its strategy and the overall quality of the underlying
fund’s manager.
The right of the Group to request redemption of its investments in collective investment schemes ranges in frequency
from weekly to annually.
The exposure to investments in collective investment schemes at fair value by strategy employed is disclosed in the
following table at 30 June 2018. These investments are included in financial assets at fair value through profit or loss
in the statement of financial position.
| Strategy |
Number of
collective
investment
schemes |
|
Net asset value
of collective
investment
schemes
R |
|
Investment
fair value
R |
|
| Multi-strategy |
4 |
|
104 436 000 000 |
|
217 278 436 |
|
The Group’s maximum exposure to loss from its interests in collective investment schemes is equal to the total fair value
of its investments in collective investment schemes.
Once the Group has disposed of its shares in a collective investment schemes, it ceases to be exposed to any risk from
that collective investment schemes.
Total purchases in collective investment schemes during the year ended 30 June 2018 was R46 million. As at 30 June 2018
and 30 June 2017, there were no capital commitment obligations and no amounts due to collective investment schemes for
unsettled purchases.
During the year ended 30 June 2018, total net gains on investments in collective investment schemes were R18.4 million.
To manage the price risk the Group’s and Company’s Investment Committee reviews its investments regularly to ensure
that the downside price risk is mitigated and assesses the economic environment to make informed decisions.
The table below summaries the impact of an increase/decrease of the share price of collective investment schemes on
the post-tax profit of the Group and Company
| Change in percentage share price |
Increase on pre-tax profit
R |
Decrease on pre-tax profit
R |
|
| 5% increase/(decrease) |
10 863 900 |
(10 863 900) |
|
| 10% increase/(decrease) |
21 727 800 |
(21 727 800) |
|
| 15% increase/(decrease) |
32 591 700 |
(32 591 700) |
|
The Group is not exposed to downside interest rate risk from external borrowings.
The Group’s and Company’s interest income arises from interest-bearing instruments and fixed deposits. The Group’s
treasury manages excess funds on a daily basis into call/deposit accounts to ensure that the best yield is obtained for the
Group.
The Group and Company has used a sensitivity analysis technique that measures the estimated change to the statement
of comprehensive income and equity of an instantaneous increase of 1% (100 basis points) in the market interest rates for
each class of financial instrument with all other variables remaining constant. The sensitivity analysis excludes the impact
of market risks on net post-employment benefit obligations.
| |
| Instruments exposed |
Increase in 1%
on statement of
comprehensive
income
R’000 |
|
Increase in 1%
on statement of
comprehensive
income
R’000 |
|
| June 2018 |
|
|
|
|
| Bank balances and short-term investments |
2 129 |
|
110 |
|
| Total |
2 129 |
|
110 |
|
| June 2017 |
|
|
|
|
| Bank balances and short-term investments |
3 982 |
|
591 |
|
| Financial assets at amortised cost |
799 |
|
799 |
|
| Total |
4 781 |
|
1 390 |
|
Under these assumptions, a 1% increase in market interest rates at 30 June 2018 would increase Group profit before tax
by approximately R2 129 000 (June 2017: R4 781 000) and Company profit before tax by approximately R 110 000
(June 2017: R1 390 000).
Credit risk arises from cash and cash equivalents and other investments, that is, deposits with banks and financial institutions,
as well as credit exposures to clients, including outstanding receivables and committed transactions. For banks and financial
institutions only independently rated parties with a minimum rating of ‘BBB’ are accepted (please refer to note 8.4). If clients
do not have an independent rating, risk control assesses the credit quality of the client, taking into account its financial
position, past experience and other factors. Credit risk is managed at both the Group and Company level.
A significant portion of the Group’s and Company’s client base comprises high-credit quality financial institutions.
Revenue from medical schemes is settled in cash.
No credit limits were exceeded during the reporting period. Individual limits are set for each client based on the factors
above as assessed by management. These limits are monitored by management and ensured that they are not
exceeded.
Prudent liquidity risk management implies maintaining sufficient cash and marketable securities, the availability of funding
through an adequate amount of committed credit facilities to meet debt repayment and operating requirements.
Management monitors the cash position on a daily basis from a Group and Company level. Due to the dynamic nature of
the underlying businesses, management flexibility in funding by keeping committed credit facilities available.
Management monitors rolling forecasts of the liquidity reserve on the basis of expected cash flow.
The table below analyses all cash flows from the financial liabilities into the time buckets in which they are contractually
due to be paid:
Time buckets applicable to the Group
| |
| |
Less than
3 months or
on demand
R’000 |
More than
3 months
but not
exceeding
6 months
R’000 |
More than
6 months
but not
exceeding
9 months
R’000 |
More than
9 months
but not
exceeding
1 year
R’000 |
Between
1 to 2 years
R’000 |
Between
2 to 3 years
R’000 |
Total
R’000 |
|
| June 2018 |
|
|
|
|
|
|
|
|
| Trade and other payables |
249 028 |
– |
– |
– |
– |
– |
284 028 |
|
| Deferred payment |
– |
– |
– |
– |
– |
5 263 |
5 263 |
|
June 2017
|
|
|
|
|
|
|
|
|
| Trade and other payables |
258 304 |
2 030 |
2 030 |
2 030 |
– |
– |
264 394 |
|
| Deferred payment |
– |
– |
– |
– |
– |
5 051 |
5 051 |
|
Time buckets applicable to the Company
| |
| |
Less than
3 months or
on demand
R’000 |
More than
3 months
but not
exceeding
6 months
R’000 |
More than
6 months
but not
exceeding
9 months
R’000 |
More than
9 months
but not
exceeding
1 year
R’000 |
Between
1 to 2 years
R’000 |
Between
2 to 3 years
R’000 |
Total
R’000 |
|
| June 2018 |
|
|
|
|
|
|
|
|
| Trade and other payables |
3 418 |
– |
– |
– |
– |
– |
3 418 |
|
| June 2017 |
|
|
|
|
|
|
|
|
| Loans from Group companies |
10 242 |
– |
– |
– |
– |
– |
10 242 |
|
| Trade and other payables |
3 103 |
5 357 |
5 357 |
5 357 |
– |
– |
19 174 |
|
The carrying value of financial liabilities at amortised cost approximates the fair value and, as a result, the fair values have
not been disclosed in the fair value hierarchy.
The objective of the Group and Company when managing capital is to safeguard its ability to continue as a going concern
in order to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital
structure to reduce the cost of capital. The Group is not subject to external capital requirements.
Consistent with others in the industry, the Group and Company monitor cash flow on the basis of the gearing ratio. This
ratio is calculated as long-term debt divided by total capital employed. Total capital employed is calculated as ‘Equity’ as
shown in the statement of financial position plus long-term debt. The Group is not subject to long-term debt as it does
not have any external capital requirements.
During 2018, the Group’s and Company’s strategy, which was unchanged from 2017, was to maintain the gearing ratio
within 0% to 15%.
|